RxDoctor Payments Data

Edward Eldred, DO

Family Medicine · Olive Branch, MSNPI 1699975425

Payments from drug & device makers

$1,401in general payments, 2019–2025

Across 91 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$382
  • AstraZeneca$183
  • Pfizer$173
  • Abbott$137
  • Amarin Pharma, Inc.$103
  • Merck$59
  • plus $364 from 14 others

What the payments were for

  • Food & beverage$1,401100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,401 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$187,759
Medicare patients
542
Services billed
3,759

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin49$53,032
OzempicSemaglutide40$47,342
TrulicityDulaglutide31$42,067
MounjaroTirzepatide33$35,162
EliquisApixaban21$28,333
ShingrixVaricella-Zoster Ge/As01b/Pf100$22,462
XareltoRivaroxaban15$12,451
Breo ElliptaFluticasone/Vilanterol19$11,528
Synjardy XrEmpagliflozin/Metformin Hcl17$11,468
ArexvyRsvpref3 Antigen/As01e/Pf34$10,971
LinzessLinaclotide12$9,066
JanuviaSitagliptin Phosphate11$6,580
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$3,351
SynthroidLevothyroxine Sodium40$3,115
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$2,020

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$14$77,22964 claims
Boehringer IngelheimJardiance, Synjardy Xr$18$64,50166 claims
Novo NordiskOzempic$382$47,34240 claims
PfizerEliquis$173$28,33321 claims
AbbVieLinzess, Synthroid$54$12,18152 claims
MerckJanuvia$59$6,58011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Olive Branch

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →